European Patent Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology
Patent application covers integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR Related patent application recently awarded in Australia; similar patents pending in other countries, favorable outcomes anticipated Billerica, Massachusetts, August 3, 2017 — MilliporeSigma today announced that the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for MilliporeSigma’s... Read more